COVID-19 vaccines are being developed and implemented with unprecedented speed. Accordingly, trials considered ethical at their inception may quickly become concerning. We provide recommendations for Data and Safety Monitoring Boards (DSMBs) on monitoring the ethical acceptability of COVID-19 vaccine trials, focusing on placebo-controlled trials in low- and middle-income countries.
History
Publication title
Clinical Infectious Diseases
Volume
73
Issue
11
Article number
2130
Number
2130
Pagination
2126
ISSN
1537-6591
Department/School
Faculty of Law
Publisher
Oxford University Press
Place of publication
Oxford, UK
Rights statement
Copyright 2021 The Authors Licensed under Creative Commons Attribution 4.0 International (CC BY 4.0) https://creativecommons.org/licenses/by/4.0/